More on CELG

- Summary
- Chart
- Profile
- Historical


- Earnings (+16.8% Growth)
- Ratings (7.5 Score)
- Holders
- Event Driven Deals


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (4/29/16 *Est.)
- Conference (2/24/2016)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

CELG Income Statement

Click line-items for a historical chart and %
Net product sales 2.31B
Collaborative agreements and other revenue 21.5M
Royalty revenue
Total revenue 2.33B
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development 1.3B
Selling, general and administrative 550.3M
Amortization of acquired intangible assets
Acquisition related (gains) charges and restructuring, net 226.2M
Total costs and expenses 2.25B
Operating income 79.6M
Other income and expense:
Interest and investment income, net 8.6M
Equity in (gains) losses of affiliated companies
Interest expense -88.5M
Other income, net -19.6M
Income before income taxes -19.9M
Income tax provision 14.2M
Net income -34.1M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic -0.04
Diluted -0.04
Weighted average shares:
Basic 791.1M
Diluted 791.1M